Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Human Liver Model Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The market for human liver models has experienced substantial expansion lately. It is projected to increase from $2.62 billion in 2025 to $2.98 billion in 2026, reflecting a compound annual growth rate (CAGR) of 13.5%. This notable growth during the preceding period can be linked to several key factors, including the rise in drug failures stemming from liver toxicity issues, the inherent constraints of conventional animal testing methods, an uptick in pharmaceutical research and development endeavors, the early integration of 2D liver cell culture systems, and an intensified emphasis on assessing drug safety.
The market for human liver models is poised for substantial expansion over the coming years, projected to reach $5.02 billion by 2030 with a compound annual growth rate of 14.0%. This upward trajectory is fueled by several key drivers, including a heightened need for precise toxicology evaluations, the proliferation of organ-on-chip technology, a stronger regulatory push to curtail animal experimentation, increased financial backing for sophisticated in vitro research instruments, and a greater reliance on human-based models during the initial stages of drug development. Significant developments anticipated within this timeframe encompass the broader integration of cutting-edge in vitro liver models for toxicity assessments, the expanding application of liver organoids in drug discovery processes, a growing inclination towards human-centric models as alternatives to animal testing, the wider deployment of liver-on-a-chip systems in preclinical investigations, and a surge in demand for tools capable of accurately predicting hepatotoxicity.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12244&type=smp
Human Liver Model Market Growth Factors Supporting Long-Term Expansion
The expansion of the human liver model market is anticipated to be fueled by a rise in clinical trial activities. These research investigations, designed to assess the safety and effectiveness of novel treatments, drugs, or medical approaches in human subjects, frequently employ human liver models. Such models are instrumental in replicating and examining drug metabolism and potential liver toxicity during the pharmaceutical development process. A notable example illustrating this trend is the report from the Association of the British Pharmaceutical Industry (ABPI) in December 2024, which indicated an increase in UK-initiated clinical trials, climbing from 411 in 2022 to 426 in 2023. Consequently, this surge in clinical trials directly contributes to the growth of the human liver model market.
Human Liver Model Market Segment Landscape And Growth Potential
The human liver model market covered in this report is segmented –
1) By Product: Liver Organoids, Liver-On-A-Chip, 2D Models, 3D Bioprinting
2) By Application: Educational, Drug Discovery, Other Applications
3) By End Users: Research Institutes, Pharmaceutical Companies, Other End Users
Subsegments:
1) By Liver Organoids: Primary Liver Organoids, Induced Pluripotent Stem Cell (iPSC)-Derived Organoids
2) By Liver-On-A-Chip: Microfluidic Liver Chips, Multi-Organ Chip Systems
3) By 2D Models: Liver Cell Cultures, Liver Cell Lines
4) By 3D Bioprinting: Bioprinted Liver Tissues, Hybrid Bioprinted Models
Human Liver Model Market Industry Trends Shaping Future Revenue Growth
Leading corporations within the human liver model sector are concentrating their efforts on creating sophisticated platforms, specifically single-organ higher throughput (HT) systems, with the dual aims of boosting the integration of predictive human liver models and securing a stronger market position. Such a single-organ higher throughput (HT) system represents a technological advancement engineered for efficient and economical drug discovery, aiming to surmount the challenges that impede the broader acceptance of predictive human liver models. As an illustration, in February of 2023, CN Bio, a firm specializing in organ-on-a-chip technology based in the United Kingdom, introduced its PhysioMimix along with the Liver-48 plate, a single-organ higher throughput (HT) system conceived to tackle the impediments obstructing the utilization of predictive human liver models in the realm of drug discovery. This innovative technology furnishes a solution that is both scalable and economically viable, empowering researchers to undertake more extensive comparative analyses concerning drug disposition, effectiveness, and safety. The Liver-48 plate itself is a multi-chip component that downscales the company’s established human liver model, making it suitable for a range of applications such as forecasting drug-induced liver damage and evaluating drug metabolism.
Human Liver Model Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the human liver model market are Corning Incorporated, EISCO Scientific LLC, BioIVT LLC, Cyprotex plc, Emulate Inc., Cellink AB, Nortis Inc., InSphero AG, CN Bio Innovations Ltd., TissUse GmbH, HemoShear Therapeutics Inc., Cyfuse Biomedical, MIMETAS BV, Biopredic International Sarl, ZenBio, Hurel Corporation, Regenovo, Pandorum, Organovo Holdings Inc., BICO Group, Hepregen Corporation, Kirkstall Ltd., HepaLife Technologies Inc., Cellaïon SA.
Access The Complete Human Liver Model Market Report:
https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report
Human Liver Model Market Regional Distribution: Which Areas Drive Market Expansion?
North Americawas the largest region in the human liver model market in 2025. The regions covered in the human liver model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
